WaveMan
WaveMan · Company
PFSA · Profusa, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

PFSA Profusa (PFSA) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0001859807
Quote by TradingView
Activist 13D
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
7
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $2.6M priced

What the filings say about PFSA

Insiders, 180 days
-$116.3K net sold
1 buyer · 1 seller · 0% of sales under a 10b5-1 plan
Activist stakes (13D), 180 days
1 filing
Largest: 49.9% of the class

Profusa insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Profusa, Inc. insiders sold a net $116.3K of stock across 14 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
HRT FINANCIAL LP
SELL
2026-08-19 SECtraded 2026-08-17
18,395
$109.3K
-88.9%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (8 buys, 5 sales), the last on Aug 14, 2026.
  • No other insider sold within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP sold about $109.3K of PFSA on Aug 17, 2026, the largest insider sale at the company on our record; 7 funds added in the latest 13F quarter.
HRT FINANCIAL LP
SELL
2026-08-18 SECtraded 2026-08-14
3,163
$2.9K
-93.8%
Context
  • 12 earlier Form 4 trades (code P or S) here by this insider (8 buys, 4 sales), the last on Aug 13, 2026.
  • The trade is 4.5% of the 71,035 shares held after it.
  • No other insider sold within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP sold about $2.9K of PFSA on Aug 14, 2026; 7 funds added in the latest 13F quarter.
HRT FINANCIAL LP
SELL
2026-08-14 SECtraded 2026-08-13
42,411
$37.7K
-81.5%
Context
  • 11 earlier Form 4 trades (code P or S) here by this insider (8 buys, 3 sales), the last on Aug 12, 2026.
  • The trade is 57.2% of the 74,198 shares held after it.
  • No other insider sold within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP sold about $37.7K of PFSA on Aug 13, 2026, the largest insider sale at the company on our record; 7 funds added in the latest 13F quarter.
HRT FINANCIAL LP
BUY
2026-08-14 SECtraded 2026-08-12
5,585
$5.4K
-81.5%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (7 buys, 3 sales), the last on Aug 11, 2026.
  • The trade is 4.8% of the 116,609 shares held after it.
  • No other insider bought within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP bought about $5.4K of PFSA on Aug 12, 2026; 7 funds added in the latest 13F quarter.
HRT FINANCIAL LP
SELL
2026-08-12 SECtraded 2026-08-11
2,280
$2.2K
-77.9%
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (7 buys, 2 sales), the last on Aug 10, 2026.
  • The trade is 2.1% of the 111,024 shares held after it.
  • No other insider sold within 30 days.
  • 7 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider HRT FINANCIAL LP sold about $2.2K of PFSA on Aug 11, 2026, the largest insider sale at the company on our record; 7 funds added in the latest 13F quarter.
14 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 9 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$116.3K over 180 days
-$116.3K over 90 days · -$116.3K of it by a 10%+ holder
more than 54% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
7 funds bought in last quarter
below 92% of Medical Devices
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
31.0% of the float short (float per yahoo 2026-10-26) · 1.0 days to cover · settled 2026-09-30
the highest in Medical Devices
The situation: each line is one rule over one dataset
NorthView Sponsor I, LLC disclosed a 5%+ stake (49.9%) in the last six months.
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch PFSA

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-99.8%12M
-100%-65%-29%+6%2025-102025-122026-022026-042026-062026-082026-10 2026-08-17 · HRT FINANCIAL LP sold $109.3K2026-08-13 · HRT FINANCIAL LP sold $37.7K2026-08-03 · HRT FINANCIAL LP bought $13.9K2026-07-31 · HRT FINANCIAL LP bought $9.3K2026-08-12 · HRT FINANCIAL LP bought $5.4K2026-08-10 · HRT FINANCIAL LP bought $3.8K2026-08-14 · HRT FINANCIAL LP sold $2.9K2026-08-11 · HRT FINANCIAL LP sold $2.2K2026-07-29 · HRT FINANCIAL LP bought $1.3K2026-08-04 · HRT FINANCIAL LP bought $1.3K2026-07-30 · HRT FINANCIAL LP bought $1.1K2026-08-07 · HRT FINANCIAL LP sold $8742026-08-06 · HRT FINANCIAL LP bought $8732026-08-05 · HRT FINANCIAL LP sold $3612026-08-19 · NorthView Sponsor I, LLC filed a 5%+ stake (49.9%)2026-08-19 · Jack Stover filed a 5%+ stake (49.9%)2026-08-19 · Fred Knechtel filed a 5%+ stake (49.9%)
Insider buyInsider sell13D/G stake
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns PFSA: institutional holders (13F)

13F holdings, latest reported quarter
StoneX Group Inc.
16,879 sh
$6.0K
GEODE CAPITAL MANAGEMENT, LLC
16,417 sh
$1.9K
VANGUARD CAPITAL MANAGEMENT LLC
3,939 sh
$457
Tower Research Capital LLC (TRC)
3,761 sh
$438
IFP Advisors, Inc
3,000 sh
$350

Congress trades in PFSA

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

13D: intends to influence · 13G: passive
NorthView Sponsor I, LLC
Activist 13D · 2026-08-19
49.9%
Jack Stover
Activist 13D · 2026-08-19
49.9%
Fred Knechtel
Activist 13D · 2026-08-19
49.9%

PFSA planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

PFSA mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Fidelity Extended Market Index Fund
$5.8K position · as of 2026-05-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$459 position · as of 2026-06-30
0.0%
Fidelity Nasdaq Composite Index Fund
$75 position · as of 2026-05-31
0.0%
Fidelity Series Total Market Index Fund
$77 position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows a net $116.3K sold by insiders over 180 days, 7 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

PFSA financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Cash flow to debt
-2.43x
TTM operating cash flow over long-term 2026-06-30 plus current 2023-12-31 (30 months older than the period end)
Return on equity
n/a
average equity is zero or negative
Return on assets
-2,860%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
n/a
capital employed is zero or negative
P/E, trailing
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Enterprise value
$8.5M
market value at close 2026-10-23 on 2026-08-18 shares, plus long-term 2026-06-30 plus current 2023-12-31 (30 months older than the period end), minus cash 2026-03-31
FCF yield
n/a
capex not filed for the four quarters
PEG, trailing
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenuen/a$100.0Kn/an/a
Operating income-$27.7M-$4.5M-$1.5M-$1.3M
Net income-$35.8M-$9.2M$1.2M$7.2M
EPS (diluted)-107.01-357.140.120.30
Operating cash flow-$16.2M-$2.1M-$2.1M-$581.2K
Cash$1.8M$191.0K$4.5K$193.5K
Long-term debt$7.9Mn/an/an/a
Buybacksn/a$3.2M$184.8Mn/a
SEC XBRL, fiscal years, as known on 2026-10-27

PFSA Stock Sonar score 4/7 axes

Find similar shapesCompare

PFSA ranks highest on insider conviction (52nd percentile) and financial health (21st), and lowest on risk and compliance (1st), among Medical Devices peers.

Financial health
21
Inputs
  • Debt to equityequity is zero or negative, the ratio has no meaning
  • Cash flow to debt-2.43x · 21 pct, sector of 150
Insider conviction
52
Inputs
  • Net Form 4 buying (codes P and S), 180d-$116K · 52 pct, sector of 140
  • Insider buyers, 180d1 · 52 pct, sector of 142
Institutional and government
8
Inputs
  • Funds adding, latest quarter7 · 8 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
1
Inputs
  • Short interest, % of float+31.0% · 1 pct, sector of 240
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+97.3% · 0 pct, sector of 198
3 not measured: Profitability, Growth, US patents
  • Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; pre-tax loss, no effective tax rate to apply
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

PFSA filings, in plain words

Are Profusa insiders buying or selling PFSA?

In the 180 days to 2026-10-27, Profusa insiders were net sellers, a net $116.3K: $36.9K of purchases and $153.2K of sales reported on Form 4, by 1 buyer and 1 seller.

Read the full summary

In the 180 days to 2026-10-27, Profusa insiders were net sellers of PFSA, a net $116.3K across purchases and sales reported on Form 4 by 1 buyer and 1 seller. Most of that figure, $116.3K, came from a holder of 10% or more rather than an officer or director. None of the 6 insider sales was flagged as made under a Rule 10b5-1 plan. 1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 49.9% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies